Cleared Traditional

K120997 - BAROSTAT SOFTWARE OPTION

K120997 is the FDA 510(k) clearance for BAROSTAT SOFTWARE OPTION by Crospon, Ltd.. It is a Class 2 Gastroenterology & Urology device (product code FFX) cleared through the Traditional 510(k) pathway after a 147-day FDA review.

K120997 · Crospon, Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
147d
Days
Class 2
Risk

K120997 is an FDA 510(k) clearance for the BAROSTAT SOFTWARE OPTION. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Crospon, Ltd. (Bonita Springs, US). The FDA issued a Cleared decision on August 27, 2012 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Crospon, Ltd. devices

Submission Details

510(k) Number K120997 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2012
Decision Date August 27, 2012
Days to Decision 147 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 130d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 18
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K120997.
EndoFLIP System
K183072 · Crospon, Ltd. · Feb 2019
SITZMARKS
K181750 · Konsyl Pharmaceuticals · Nov 2018
Lehman Manometry Catheter
K160170 · Wilson-Cook Medical, Inc. · Jun 2016
WILSON-COOK BILIARY MOTILITY CATHETER
K900058 · Wilson-Cook Medical, Inc. · Jul 1990
GASTROPLASTY CALIBRATING TUBE & GASTROSTENOMETER
K874690 · Mentor Corp. · Feb 1988
SYN-02 PN AMPLIFIER
K830421 · Biosearch Medical Products, Inc. · Apr 1983